CHEBI:140238 - (4Z,7Z,10Z,13Z,15E,19Z)-17-oxodocosahexaenoic acid

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name (4Z,7Z,10Z,13Z,15E,19Z)-17-oxodocosahexaenoic acid
ChEBI ASCII Name (4Z,7Z,10Z,13Z,15E,19Z)-17-oxodocosahexaenoic acid
Definition An oxodocosahexaenoic acid that is (4Z,7Z,10Z,13Z,15E,19Z)-docosahexaenoic acid in which the oxo group is located at position 17. An intermediate of specialised proresolving mediators.
Stars This entity has been manually annotated by the ChEBI Team.
Submitter Bijay
Supplier Information
Download Molfile XML SDF
Formula C22H30O3
Net Charge 0
Average Mass 342.473
Monoisotopic Mass 342.21949
InChI InChI=1S/C22H30O3/c1-2-3-15-18-21(23)19-16-13-11-9-7-5-4-6-8-10-12-14-17-20-22(24)25/h3,5-8,11-16,19H,2,4,9-10,17-18,20H2,1H3,(H,24,25)/b7-5-,8-6-,13-11-,14-12-,15-3-,19-16+
Metabolite of Species Details
Homo sapiens (NCBI:txid9606) See: PubMed
Roles Classification
Chemical Role(s): Bronsted acid
A molecular entity capable of donating a hydron to an acceptor (Bronsted base).
(via oxoacid )
Biological Role(s): human xenobiotic metabolite
Any human metabolite produced by metabolism of a xenobiotic compound in humans.
PPARalpha agonist
A PPAR modulator which activates the peroxisome proliferator-activated receptor-alpha.
PPARgamma agonist
A PPAR modulator which activates the peroxisome proliferator-activated receptor-gamma.
Application(s): anti-inflammatory agent
Any compound that has anti-inflammatory effects.
antineoplastic agent
A substance that inhibits or prevents the proliferation of neoplasms.
View more via ChEBI Ontology
ChEBI Ontology
Outgoing (4Z,7Z,10Z,13Z,15E,19Z)-17-oxodocosahexaenoic acid (CHEBI:140238) has functional parent all-cis-docosa-4,7,10,13,16,19-hexaenoic acid (CHEBI:28125)
(4Z,7Z,10Z,13Z,15E,19Z)-17-oxodocosahexaenoic acid (CHEBI:140238) has role anti-inflammatory agent (CHEBI:67079)
(4Z,7Z,10Z,13Z,15E,19Z)-17-oxodocosahexaenoic acid (CHEBI:140238) has role antineoplastic agent (CHEBI:35610)
(4Z,7Z,10Z,13Z,15E,19Z)-17-oxodocosahexaenoic acid (CHEBI:140238) has role human xenobiotic metabolite (CHEBI:76967)
(4Z,7Z,10Z,13Z,15E,19Z)-17-oxodocosahexaenoic acid (CHEBI:140238) has role PPARα agonist (CHEBI:70782)
(4Z,7Z,10Z,13Z,15E,19Z)-17-oxodocosahexaenoic acid (CHEBI:140238) has role PPARγ agonist (CHEBI:71554)
(4Z,7Z,10Z,13Z,15E,19Z)-17-oxodocosahexaenoic acid (CHEBI:140238) is a enone (CHEBI:51689)
(4Z,7Z,10Z,13Z,15E,19Z)-17-oxodocosahexaenoic acid (CHEBI:140238) is a oxodocosahexaenoic acid (CHEBI:134542)
(4Z,7Z,10Z,13Z,15E,19Z)-17-oxodocosahexaenoic acid (CHEBI:140238) is conjugate acid of (4Z,7Z,10Z,13Z,15E,19Z)-17-oxodocosahexaenoate (CHEBI:140316)
Incoming (4Z,7Z,10Z,13Z,15E,19Z)-17-oxodocosahexaenoate (CHEBI:140316) is conjugate base of (4Z,7Z,10Z,13Z,15E,19Z)-17-oxodocosahexaenoic acid (CHEBI:140238)
(4Z,7Z,10Z,13Z,15E,19Z)-17-oxodocosa-4,7,10,13,15,19-hexaenoic acid
Synonyms Sources
17-oxo-(4Z,7Z,10Z,13Z,15E,19Z)-docosahexaenoic acid ChEBI
17-oxodocosahexaenoic acid ChEBI
Registry Number Type Source
26960428 Reaxys Registry Number Reaxys
Citations Waiting for Citations Types Sources
24594225 PubMed citation Europe PMC
26339618 PubMed citation Europe PMC
27337155 PubMed citation Europe PMC
27883019 PubMed citation Europe PMC
29435611 PubMed citation Europe PMC
Last Modified
02 March 2018